Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit

被引:10
|
作者
Hsiao, Hsiang-Ju [1 ,2 ]
Wu, Chang-Teng [2 ,3 ]
Huang, Jing-Long [2 ,4 ]
Chiu, Cheng-Hsun [2 ,5 ]
Huang, Yhu-Chering [2 ,6 ]
Lin, Jainn-Jim [2 ,7 ]
Huang, I-Anne [1 ,2 ]
Chan, Oi-Wa [2 ,7 ]
Chou, I-Jun [2 ,3 ]
Hsia, Shao-Hsuan [2 ,7 ]
机构
[1] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Pediat, Div Gen Pediat, Linkou, Taiwan
[4] Chang Gung Mem Hosp, Dept Pediat, Div Asthma Allergy & Rheumatol, Linkou, Taiwan
[5] Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Div Pediat Infect, Linkou, Taiwan
[6] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Linkou, Taiwan
[7] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Crit Care Med, Linkou, Taiwan
来源
BMC PEDIATRICS | 2015年 / 15卷
关键词
Hemolytic uremic syndrome (HUS); herd immunity; invasive pneumococcal disease; mortality; pediatric intensive care unit; pneumococcal conjugate vaccine; serotype; 19; F; Streptococcus pneumoniae; HEMOLYTIC-UREMIC SYNDROME; CONJUGATE VACCINE; BACTERIAL-MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; SEROTYPE; 19A; TAIWAN; CHILDREN; SURVEILLANCE; EMERGENCE; ADULTS;
D O I
10.1186/s12887-015-0387-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Invasive pneumococcal disease (IPD) results in high morbidity and mortality globally each year, although it is a vaccine-preventable disease. This study aimed to characterize the clinical features of IPD in a pediatric intensive care unit (PICU) in Taiwan. The seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the private sector in October 2005. The estimated coverage rate of PCV7 vaccination in 2010 was 45.5 % among children < 5 years of age. Methods: We conducted a retrospective study at a single center in northern Taiwan for invasive pneumococcal disease in a PICU from 2009 to 2013. Demographic characteristics, clinical courses, serotype, antibiotic susceptibility, and outcomes were analyzed. Results: Over the 5-year study period, 2167 patients were admitted to the PICU; 48 (2.2 %) had IPD. There were 29 female and 19 male patients. Their mean age was 3.7 years (range 0.7-12.5 years, with the peak age at 2-5 years; n = 30, 63 %). Pneumonia was the most frequent type (n = 38, 79 %), followed by meningitis (n = 10, 21 %). In total, three patients died, all within 72 h after admission; the final diagnoses were all meningitis. Thirty-four children with pneumonia received chest tube insertion for pleural effusion drainage. Of them, 22 (65 %) finally still underwent video-assisted thoracoscopic surgery. Eight (17 %) children had hemolytic uremic syndrome, and seven of them underwent hemodialysis. In total, 37 serotypes were detected; 95 % were covered by PCV13. Serotype 19A was most common (54 %) overall; however, in those with meningitis, serotype 19 F was most common. Conclusions: Meningitis is the most severe type of invasive pneumococcal disease in our pediatric intensive care unit. It may progress rapidly even when subjects are given antibiotics promptly. The most common serotype in meningitis is 19 F, which is vaccine preventable. Thus, universal mass pneumococcal vaccination is still needed.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Clinical Features of Invasive Pneumococcal Disease in Korea
    Choi, Won Suk
    Noh, Ji Yun
    Huh, Joong Yeon
    Youn, Young Kyoung
    Kim, Mi Jeong
    Jo, Yu Mi
    Kim, Jeong Yeon
    Song, Joon Young
    Park, Dae Won
    Kim, Woo Joo
    Kim, Min Ja
    Cheong, Hee Jin
    INFECTION AND CHEMOTHERAPY, 2010, 42 (03) : 156 - 161
  • [22] Early clinical predictors for the prognosis of invasive pneumococcal disease
    Shuiyan Wu
    Xubei Guo
    Zhong Xu
    Meilin Han
    Lili Huang
    Yunzhen Tao
    Ying Li
    Yanhong Li
    Tao Zhang
    Zhenjiang Bai
    BMC Infectious Diseases, 20
  • [23] Effect of Age on the Manifestations and Outcomes of Invasive Pneumococcal Disease in Adults
    Marrie, Thomas J.
    Tyrrell, Gregory J.
    Majumdar, Sumit R.
    Eurich, Dean T.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (01) : 100.e1 - 100.e7
  • [24] Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands
    Wagenvoort, Gertjan H. J.
    Knol, Mirjam J.
    de Melker, Hester E.
    Vlaminckx, Bart J.
    van der Ende, Arie
    Rozenbaum, Mark H.
    Sanders, Elisabeth A. M.
    VACCINE, 2016, 34 (03) : 334 - 340
  • [25] Clinical Presentation of Invasive Pneumococcal Disease in Spain in the Era of Heptavalent Conjugate Vaccine
    de Sevilla, Maria F.
    Garcia-Garcia, Juan-Jose
    Esteva, Cristina
    Moraga, Fernando
    Hernandez, Sergi
    Selva, Laura
    Coll, Francisco
    Ciruela, Pilar
    Maria Planes, Ana
    Codina, Gemma
    Salleras, Luis
    Jordan, Iolanda
    Dominguez, Angela
    Munoz-Almagro, Carmen
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (02) : 124 - 128
  • [26] Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types
    Browall, Sarah
    Backhaus, Erik
    Naucler, Pontus
    Galanis, Ilias
    Sjostrom, Karin
    Karlsson, Diana
    Berg, Stefan
    Luthander, Joachim
    Eriksson, Margareta
    Spindler, Carl
    Ejdeback, Mikael
    Trollfors, Birger
    Darenberg, Jessica
    Kalin, Mats
    Ortqvist, Ake
    Andersson, Rune
    Henriques-Normark, Birgitta
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (06) : 1646 - 1657
  • [27] Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination
    Grant, Lindsay R.
    Slack, Mary P. E.
    Theilacker, Christian
    Vojicic, Jelena
    Dion, Stephane
    Reinert, Ralf Rene
    Jodar, Luis
    Gessner, Bradford D.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E1062 - E1070
  • [28] INVASIVE PNEUMOCOCCAL DISEASE IN A PEDIATRIC POPULATION, AUCKLAND, NEW-ZEALAND
    VOSS, L
    LENNON, D
    OKESENEGAFA, K
    AMERATUNGA, S
    MARTIN, D
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (10) : 873 - 878
  • [29] Hemophagocytic lymphohistiocytosis complicating invasive pneumococcal disease: a pediatric case report
    Tsuge, Mitsuru
    Miyamoto, Machiko
    Miyawaki, Reiji
    Kondo, Yoichi
    Tsukahara, Hirokazu
    BMC PEDIATRICS, 2020, 20 (01)
  • [30] Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA
    Tan, Tina Q.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (02) : 117 - 125